Shanghai HeartCare Medical Technology Corporation Limited
HKEX:6609.HK
20 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 61.379 | 61.379 | 54.793 | 54.793 | 53.16 | 53.16 | 38.357 | 38.357 | 29.982 | 29.982 | 16.506 | 13.619 | 6.196 | 6.196 | 1.802 | 0.369 |
| Cost of Revenue
| 25.341 | 25.341 | 14.934 | 14.934 | 16.651 | 16.651 | 12.924 | 12.924 | 12.033 | 12.033 | 6.271 | 4.802 | 3.199 | 3.199 | 0.866 | 0.211 |
| Gross Profit
| 36.038 | 36.038 | 39.859 | 39.859 | 36.509 | 36.509 | 25.433 | 25.433 | 17.949 | 17.949 | 10.235 | 8.817 | 2.997 | 2.997 | 0.936 | 0.158 |
| Gross Profit Ratio
| 0.587 | 0.587 | 0.727 | 0.727 | 0.687 | 0.687 | 0.663 | 0.663 | 0.599 | 0.599 | 0.62 | 0.647 | 0.484 | 0.484 | 0.519 | 0.428 |
| Reseach & Development Expenses
| 26.991 | 26.991 | 34.925 | 34.925 | 46.393 | 46.393 | 30.454 | 30.454 | 21.957 | 21.957 | 17.347 | 15.045 | 20.263 | 20.263 | 4.706 | 5.902 |
| General & Administrative Expenses
| 22.411 | 22.411 | 14.907 | 14.907 | 16.585 | 16.585 | 19.148 | 19.148 | 17.66 | 17.66 | 51.102 | 14.814 | 69.305 | 69.305 | 2.927 | 0.332 |
| Selling & Marketing Expenses
| 18.792 | 18.792 | 20.831 | 20.831 | 30.275 | 30.275 | 17.989 | 17.989 | 16.366 | 16.366 | 11.914 | 6.482 | 5.578 | 5.578 | 1.723 | 1.399 |
| SG&A
| 41.203 | 41.203 | 35.738 | 35.738 | 46.86 | 46.86 | 37.137 | 37.137 | 34.026 | 34.026 | 63.016 | 21.296 | 74.883 | 74.883 | 4.65 | 1.731 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -17.828 | 15.951 | 0 | 0 | -1.925 | 1.538 |
| Operating Expenses
| 62.045 | 62.045 | 69.831 | 69.831 | 107.132 | 107.132 | 61.932 | 61.932 | 71.089 | 71.089 | 62.535 | 52.292 | 102.712 | 102.712 | 7.431 | 9.171 |
| Operating Income
| -31.307 | -31.307 | -32.128 | -32.128 | -57.423 | -57.423 | -42.388 | -42.388 | -39.227 | -39.227 | -52.694 | -41.701 | -92.657 | -92.657 | -6.463 | -8.988 |
| Operating Income Ratio
| -0.51 | -0.51 | -0.586 | -0.586 | -1.08 | -1.08 | -1.105 | -1.105 | -1.308 | -1.308 | -3.192 | -3.062 | -14.956 | -14.956 | -3.587 | -24.358 |
| Total Other Income Expenses Net
| 7.165 | 7.165 | 4.81 | 4.81 | -9.71 | -9.71 | 8.896 | 8.896 | -12.891 | -12.891 | -0.074 | 0.404 | -7.518 | -7.518 | -0.228 | -0.098 |
| Income Before Tax
| -24.142 | -24.142 | -27.318 | -27.318 | -67.132 | -67.132 | -33.493 | -33.493 | -52.118 | -52.118 | -52.374 | -41.297 | -100.175 | -100.175 | -6.723 | -9.111 |
| Income Before Tax Ratio
| -0.393 | -0.393 | -0.499 | -0.499 | -1.263 | -1.263 | -0.873 | -0.873 | -1.738 | -1.738 | -3.173 | -3.032 | -16.169 | -16.169 | -3.731 | -24.691 |
| Income Tax Expense
| 4.305 | 4.305 | 0.149 | 0.149 | 0.348 | 0.348 | 0.085 | 0.085 | -0.856 | -0.856 | -0.793 | -1.9 | -1.26 | -1.26 | 0.26 | 0.123 |
| Net Income
| -19.837 | -19.837 | -27.169 | -27.169 | -66.784 | -66.784 | -33.408 | -33.408 | -51.262 | -51.262 | -51.581 | -39.397 | -98.915 | -98.915 | -6.983 | -9.234 |
| Net Income Ratio
| -0.323 | -0.323 | -0.496 | -0.496 | -1.256 | -1.256 | -0.871 | -0.871 | -1.71 | -1.71 | -3.125 | -2.893 | -15.966 | -15.966 | -3.875 | -25.024 |
| EPS
| -0.52 | -0.52 | -0.71 | -0.71 | -1.74 | -1.74 | -0.88 | -0.88 | -1.41 | -1.41 | -1.33 | -1.01 | -4.29 | -4.29 | -0.18 | -0.24 |
| EPS Diluted
| -0.52 | -0.52 | -0.71 | -0.71 | -1.74 | -1.74 | -0.88 | -0.88 | -1.41 | -1.41 | -1.33 | -1.01 | -4.29 | -4.29 | -0.18 | -0.24 |
| EBITDA
| -25.301 | -25.301 | -25.983 | -25.983 | -50.375 | -50.375 | -36.466 | -36.466 | -36.938 | -36.938 | -48.942 | -38.506 | -91.347 | -91.347 | -4.418 | -6.96 |
| EBITDA Ratio
| -0.412 | -0.412 | -0.474 | -0.474 | -0.948 | -0.948 | -0.951 | -0.951 | -1.232 | -1.232 | -3.028 | -2.895 | -14.744 | -14.744 | -2.466 | -18.862 |